Your Article Summary
See Latest ArticlesSafety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studies
Current Medical Research and Opinion, 06/24/09
Cantor LB et al. - Brimonidine P 0.1% has improved systemic safety and tolerability compared with brimonidine P 0.15%. The ocular safety and tolerability of the formulations are similar. The present meta-analysis is based on only two clinical studies, and additional studies further evaluating the safety and tolerability of these medications are warranted.
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
Nplate Data From MDS Studies Presented at ASH
Amgen, 12/07/09
A Multicenter, Double-Blind, Randomized, Parallel Group Study Comparing Polyvinyl Chloride and Polyvinyl Chloride-Free Catheter Materials
The Journal of Urology, 11/24/09
Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study
Anticancer Research, 11/16/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Benefits of budesonide or nedocromil for mild to moderate asthma in children were not sustained after discontinuation
Evidence-Based Medicine, 12/07/09
Treatment strategies for juvenile idiopathic arthritis
Expert Opinion in Pharmacotherapy, 12/07/09
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders
Journal of Dermatological Treatment , 12/04/09